...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Idea for Zenith

I sooner move on the venture exchange than just trading on the OTC. But it may be too late for that to happen. As you say it would cost us a ton of dilution but in my opinion, it may improve the stock price with a much bigger volume that may be at play.

 

Koo

Share
New Message
Please login to post a reply